Abstract
This article presents the outcomes of the VI Annual Scientific and Practical Conference with international participation "RWD/RWE. Possible and Real", which focused on the use of Real-World Data (RWD) and Real-World Evidence (RWE) in healthcare. The event facilitated a comprehensive analysis of the current state of RWD/RWE regulatory frameworks, methodological approaches, and practical applications in the Russian Federation and the Eurasian Economic Union (EAEU). Key systemic limitations were identified, including gaps in legislation, the lack of standardized methods for data collection and analysis, interoperability issues of information systems, and challenges related to confidentiality and personal data processing. A set of specific proposals and recommendations aimed at improving the regulatory framework, developing in- frastructure for working with RWD, integrating such data into health technology assessment processes, developing clinical guidelines, and implementing innovative drug supply models. Harmonizing approaches at the EAEU level, data standardization, and creating secure mechanisms for researchers and developers to access anonymized medical information are of particular importance. The resolution materials are intended for legislative and executive authorities, regulators, medical and scientific organizations, pharmaceutical industry representatives, and patient communities.